Allogene Therapeutics
$1.9750
140
-$0.00-0.25% 18:04 Today
Statistics
Day High
2.01
Day Low
1.95
52W High
3.06
52W Low
1.05
Volume
3,069,366
Avg. Volume
7,436,690
Mkt Cap
682.34M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
29OctExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.33
-0.26
-0.2
-0.13
Expected EPS
-0.146618
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-190.89MNet Income
Analyst Ratings
8.21Average Price Target
The highest estimate is 14.00.
From 9 ratings within the last 6 months. This is not an investment recommendation.
From 9 ratings within the last 6 months. This is not an investment recommendation.
Buy 56%
Hold 44%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ALLO. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap180.64B
Novartis
NVS
Mkt Cap292.35B
CRISPR Therapeutics
CRSP
Mkt Cap5.58B
Precigen
PGEN
Mkt Cap2.49B
Fate Therapeutics
FATE
Mkt Cap291.16M
About
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
Show more...
CEO
Zachary Roberts
Employees
152
Country
United States
ISIN
US0197701065
Listings
0 Comments
Share your thoughts
FAQ
What is Allogene Therapeutics stock price today?▼
The current price of ALLO is $1.98 USD — it has decreased by -0.25% in the past 24 hours. Watch Allogene Therapeutics stock price performance more closely on the chart.
What is Allogene Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Allogene Therapeutics stocks are traded under the ticker ALLO.
Is Allogene Therapeutics stock price growing?▼
ALLO stock has fallen by -2.23% compared to the previous week, the month change is a +3.95% rise, over the last year Allogene Therapeutics has showed a +77.93% increase.
What is Allogene Therapeutics market cap?▼
Today Allogene Therapeutics has the market capitalization of 682.34M
When is the next Allogene Therapeutics earnings date?▼
Allogene Therapeutics is going to release the next earnings report on October 29, 2026.
What were Allogene Therapeutics earnings last quarter?▼
ALLO earnings for the last quarter are -0.13 USD per share, whereas the estimation was -0.17 USD resulting in a +24.14% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Allogene Therapeutics revenue for the last year?▼
Allogene Therapeutics revenue for the last year amounts to 0 USD.
What is Allogene Therapeutics net income for the last year?▼
ALLO net income for the last year is -190.89M USD.
How many employees does Allogene Therapeutics have?▼
As of September 04, 2026, the company has 152 employees.
In which sector is Allogene Therapeutics located?▼
Allogene Therapeutics operates in the Health & Wellness sector.
When did Allogene Therapeutics complete a stock split?▼
Allogene Therapeutics has not had any recent stock splits.
Where is Allogene Therapeutics headquartered?▼
Allogene Therapeutics is headquartered in SOUTH SAN FRANCISCO, United States.